129 results
Page 5 of 7
8-K
EX-99.1
twjc o749apm49w
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
ihh397m
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
yvfrkp1lffqrq1r
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-10.1
gg2h1
18 Apr 19
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.1
3qm0p7on 63mn8d4
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
pxf50 t1i9xcl1s5j
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm
DEFA14A
yniq5
21 Mar 19
Additional proxy soliciting materials
12:00am
8-K/A
EX-10.1
m2wiszhnb9oho 7hh
6 Mar 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-10.1
sbxj2v
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
424B5
lkupfeaysml3j bg1zs
19 Feb 19
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
fmftd
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-10.1
79ep5gf tg
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
1gs3wxbejlj 00taq4kb
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am